The results of the CIHR Project Grants for the Fall 2023 competition, known for its competitiveness, indicate that 4 proposals from CRC researchers have been successfully selected!
The selected projects are as follows:
Guy Poirier, in collaboration with Jean-Yves Masson and Michael J. Hendzel (Universisty of L’Alberta)
- Title: Emerging roles of Zinc Finger PAR-Interacting Proteins (ZIPPs) in DNA double-strand break (DSB) repair: implications in PARPi therapy More info
Jacques Simard, in collaboration with Jean-Yves Masson, Arnaud Droit, Antonis Antoniou and Douglas Easton (University of Cambridge)
- Title: Characterization of novel breast cancer susceptibility genes through large-scale targeted sequencing and functional assays More info
Sheng-Xiang Lin, in collaboration with Donald Poirier
- Title: Pre-clinical pharmacokinetic and efficacy assays with an efficient 17beta-hydroxysteroid dehydrogenase type 7 inhibitor for breast cancer therapy More info
Tom Moss
- Title: The Ribosomal RNA Genes in Growth, Pluripotency, Senescence and Cancer More info
Congratulations!